33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
Engraftment of Vertex Pharmaceutical's VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent at 1 year.
Source: medscape.com
Page 2 - Universal Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Universal Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Universal Cells Today - Breaking & Trending Today
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Astellas Pharma agreed to acquire Iveric Bio for approximately $5.9 billion, in a deal designed to expand the buyer’s eye treatment pipeline.
Source: genengnews.com
Adaptimmune, TCR2 Therapeutics to Combine in Marriage of Cell Therapy Developers
Adaptimmune and TCR2 Therapeutics have complementary technologies and an aligned strategy of developing cell therapies for solid tumors, but this marriage is preceded by divorce. Before consummating the TCR2 deal, Adaptimmune ended an alliance with a larger pharmaceutical company.
Source: medcitynews.com
Adaptimmune Therapeutics PLC: Adaptimmune Reports Fourth-Quarter and Full Year Financial Results and Business Update
BLA submission initiated for afami-cel, with aim to complete in mid-2023; afami-cel has the potential to be the first marketed engineered TCR T-cell therapy for a solid tumor52% (13/25) response rate
Source: finanznachrichten.de
Igniting Innovation Through Partnership A New Model To Accelerate Cancer Cell Therapy For Patients
To advance the field of immuno-oncology, we must shift our mindsets and ways of working to embrace agile practices and new levels of knowledge...
Source: lifescienceleader.com